Market Closed -
Japan Exchange
02:00:00 2024-05-10 am EDT
|
5-day change
|
1st Jan Change
|
2,397
JPY
|
+2.02%
|
|
+1.96%
|
-0.44%
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
216,479
|
209,807
|
293,430
|
187,568
|
229,932
|
226,157
|
-
|
-
|
Enterprise Value (EV)
1 |
214,900
|
193,557
|
284,484
|
174,979
|
223,031
|
198,324
|
192,038
|
182,863
|
P/E ratio
|
20
x
|
17.8
x
|
23.9
x
|
15.4
x
|
19.1
x
|
14.4
x
|
14.9
x
|
14
x
|
Yield
|
1.54%
|
1.69%
|
1.29%
|
2.06%
|
1.72%
|
2.38%
|
2.12%
|
2.24%
|
Capitalization / Revenue
|
0.49
x
|
0.43
x
|
0.59
x
|
0.36
x
|
0.4
x
|
0.31
x
|
0.34
x
|
0.33
x
|
EV / Revenue
|
0.48
x
|
0.4
x
|
0.57
x
|
0.34
x
|
0.39
x
|
0.31
x
|
0.29
x
|
0.27
x
|
EV / EBITDA
|
9.67
x
|
8.23
x
|
10.6
x
|
6.73
x
|
7.8
x
|
6.2
x
|
5.55
x
|
5.1
x
|
EV / FCF
|
30.8
x
|
10.3
x
|
589
x
|
20.4
x
|
30.4
x
|
9.64
x
|
19.9
x
|
9.53
x
|
FCF Yield
|
3.24%
|
9.74%
|
0.17%
|
4.89%
|
3.29%
|
10.4%
|
5.04%
|
10.5%
|
Price to Book
|
2.27
x
|
2.06
x
|
2.63
x
|
1.59
x
|
1.8
x
|
1.42
x
|
1.51
x
|
1.41
x
|
Nbr of stocks (in thousands)
|
95,260
|
94,828
|
94,350
|
94,350
|
94,350
|
94,350
|
-
|
-
|
Reference price
2 |
2,272
|
2,212
|
3,110
|
1,988
|
2,437
|
2,397
|
2,397
|
2,397
|
Announcement Date
|
5/10/19
|
5/12/20
|
5/11/21
|
5/10/22
|
5/12/23
|
5/10/24
|
-
|
-
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
444,048
|
484,395
|
497,156
|
514,353
|
572,285
|
630,988
|
657,300
|
687,350
|
EBITDA
1 |
22,223
|
23,531
|
26,927
|
25,993
|
28,594
|
31,974
|
34,583
|
35,890
|
EBIT
1 |
17,952
|
18,794
|
21,800
|
20,505
|
21,144
|
24,535
|
26,488
|
28,152
|
Operating Margin
|
4.04%
|
3.88%
|
4.38%
|
3.99%
|
3.69%
|
3.89%
|
4.03%
|
4.1%
|
Earnings before Tax (EBT)
1 |
18,490
|
19,870
|
21,235
|
20,804
|
20,665
|
21,860
|
26,800
|
28,500
|
Net income
1 |
11,236
|
11,803
|
12,280
|
12,172
|
12,063
|
13,789
|
15,800
|
16,488
|
Net margin
|
2.53%
|
2.44%
|
2.47%
|
2.37%
|
2.11%
|
2.19%
|
2.4%
|
2.4%
|
EPS
2 |
113.9
|
124.0
|
130.0
|
129.0
|
127.8
|
146.2
|
160.9
|
170.9
|
Free Cash Flow
1 |
6,973
|
18,845
|
483
|
8,558
|
7,331
|
20,802
|
9,674
|
19,184
|
FCF margin
|
1.57%
|
3.89%
|
0.1%
|
1.66%
|
1.28%
|
3.34%
|
1.47%
|
2.79%
|
FCF Conversion (EBITDA)
|
31.38%
|
80.09%
|
1.79%
|
32.92%
|
25.64%
|
64.84%
|
27.97%
|
53.45%
|
FCF Conversion (Net income)
|
62.06%
|
159.66%
|
3.93%
|
70.31%
|
60.77%
|
156.02%
|
61.23%
|
116.36%
|
Dividend per Share
2 |
35.00
|
37.50
|
40.00
|
41.00
|
42.00
|
50.00
|
50.75
|
53.75
|
Announcement Date
|
5/10/19
|
5/12/20
|
5/11/21
|
5/10/22
|
5/12/23
|
5/10/24
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2021 S1
|
2021 S2
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
242,232
|
220,731
|
276,425
|
120,448
|
234,663
|
128,491
|
151,199
|
279,690
|
121,214
|
142,306
|
263,520
|
143,600
|
165,165
|
146,467
|
150,304
|
296,771
|
156,286
|
177,931
|
150,553
|
157,543
|
168,576
|
180,194
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
10,081
|
7,832
|
13,968
|
4,487
|
7,593
|
4,766
|
8,146
|
12,912
|
2,830
|
5,141
|
7,971
|
5,445
|
7,728
|
3,842
|
5,396
|
9,238
|
5,892
|
9,405
|
3,984
|
5,454
|
6,432
|
10,782
|
Operating Margin
|
4.16%
|
3.55%
|
5.05%
|
3.73%
|
3.24%
|
3.71%
|
5.39%
|
4.62%
|
2.33%
|
3.61%
|
3.02%
|
3.79%
|
4.68%
|
2.62%
|
3.59%
|
3.11%
|
3.77%
|
5.29%
|
2.65%
|
3.46%
|
3.82%
|
5.98%
|
Earnings before Tax (EBT)
1 |
10,997
|
8,098
|
13,137
|
4,318
|
7,376
|
4,996
|
8,432
|
13,428
|
2,903
|
4,640
|
7,543
|
5,390
|
7,732
|
4,558
|
2,834
|
7,392
|
5,665
|
8,803
|
4,134
|
5,504
|
6,532
|
10,882
|
Net income
1 |
6,693
|
4,711
|
7,569
|
2,516
|
4,118
|
2,865
|
5,189
|
8,054
|
1,585
|
2,558
|
4,143
|
3,307
|
4,613
|
2,998
|
688
|
3,686
|
3,538
|
6,565
|
2,471
|
3,064
|
3,862
|
6,802
|
Net margin
|
2.76%
|
2.13%
|
2.74%
|
2.09%
|
1.75%
|
2.23%
|
3.43%
|
2.88%
|
1.31%
|
1.8%
|
1.57%
|
2.3%
|
2.79%
|
2.05%
|
0.46%
|
1.24%
|
2.26%
|
3.69%
|
1.64%
|
1.95%
|
2.29%
|
3.77%
|
EPS
2 |
70.27
|
49.82
|
-
|
26.66
|
43.65
|
30.36
|
55.00
|
-
|
16.80
|
-
|
43.92
|
35.04
|
-
|
31.78
|
7.290
|
39.07
|
37.50
|
69.58
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
41.00
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
48.00
|
-
|
-
|
-
|
50.00
|
Announcement Date
|
11/8/19
|
11/10/20
|
5/11/21
|
11/9/21
|
11/9/21
|
2/8/22
|
5/10/22
|
5/10/22
|
8/9/22
|
11/8/22
|
11/8/22
|
2/7/23
|
5/12/23
|
8/8/23
|
11/10/23
|
11/10/23
|
2/9/24
|
5/10/24
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,579
|
16,250
|
8,946
|
12,589
|
6,901
|
25,662
|
34,120
|
43,294
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
6,973
|
18,845
|
483
|
8,558
|
7,331
|
20,802
|
9,674
|
19,184
|
ROE (net income / shareholders' equity)
|
11.5%
|
12%
|
11.5%
|
10.6%
|
9.8%
|
10.3%
|
11%
|
10.8%
|
ROA (Net income/ Total Assets)
|
6.34%
|
6.56%
|
6.76%
|
6.36%
|
5.75%
|
6.56%
|
5.4%
|
5.45%
|
Assets
1 |
177,237
|
180,052
|
181,531
|
191,432
|
209,875
|
210,211
|
292,593
|
302,523
|
Book Value Per Share
2 |
1,002
|
1,073
|
1,181
|
1,254
|
1,357
|
1,479
|
1,585
|
1,700
|
Cash Flow per Share
2 |
143.0
|
157.0
|
164.0
|
167.0
|
183.0
|
204.0
|
247.0
|
254.0
|
Capex
1 |
3,561
|
5,165
|
4,951
|
3,235
|
4,034
|
4,050
|
4,000
|
4,650
|
Capex / Sales
|
0.8%
|
1.07%
|
1%
|
0.63%
|
0.7%
|
0.65%
|
0.61%
|
0.68%
|
Announcement Date
|
5/10/19
|
5/12/20
|
5/11/21
|
5/10/22
|
5/12/23
|
5/10/24
|
-
|
-
|
Last Close Price
2,397
JPY Average target price
2,805
JPY Spread / Average Target +17.02% Consensus |
1st Jan change
|
Capi.
|
---|
| -0.44% | 1.45B | | -3.32% | 1.43B | | -5.79% | 1.21B | | -14.59% | 899M | | +1.72% | 480M | | +3.85% | 440M | | -48.41% | 369M | | -19.75% | 356M | | -2.93% | 213M | | -28.04% | 209M |
Medical Equipment Wholesale
|